Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Bessent: BOJ's Ueda must be free on ratesPrimis director buys $19,965 in stockBlanche Won't Rule Out Trump Fund Payouts to Police AttackersAI flaws surpass stolen credentialsMbappe transfer: Chelsea owner contacted his motherInuvo PT Cut to $2.50 After Weak Q1Kyntra Bio CEO Buys $19,852 in StockEagle Capital CEO buys $12.3k in GRF sharesVance: 'A lot of progress' in Iran talksOneok stock hits 52-week high at $95.31Bessent: BOJ's Ueda must be free on ratesPrimis director buys $19,965 in stockBlanche Won't Rule Out Trump Fund Payouts to Police AttackersAI flaws surpass stolen credentialsMbappe transfer: Chelsea owner contacted his motherInuvo PT Cut to $2.50 After Weak Q1Kyntra Bio CEO Buys $19,852 in StockEagle Capital CEO buys $12.3k in GRF sharesVance: 'A lot of progress' in Iran talksOneok stock hits 52-week high at $95.31
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#cinclus-pharma

Latest news and interesting information about cinclus-pharma.

Cinclus Pharma Q1 2026 Revenue Milestone Boosts Stock
Today / 18:11
|
685

Cinclus Pharma Q1 2026 Revenue Milestone Boosts Stock

Cinclus Pharma Q1 2026 earnings: first revenue of SEK 10 million, stock up 4.08%. New partnerships and financing boost confidence.

TRANSCRIPTS →
0
...